Stock Taper
EARNINGS CALL ARCHIVE 4 CALLS ON FILE
NUS — Nu Skin Enterprises, Inc.
NYSE
FULL STOCK PAGE →

Nu Skin Enterprises Q4 2025 Earnings Call Summary

FEB 12, 2026 2 MIN READ
REVENUE
$370.3M +1.7%
NET MARGIN
3.9% -0.8 PTS
EPS
$0.30 -14.3%
FREE CASH FLOW
$5.9M -66.6%

1Key Financial Results and Metrics

Q4 2025 Revenue: $370 million, within guidance; impacted by $1 million foreign currency headwind.

Earnings Per Share (EPS): $0.29, in line with expectations.

Full Year 2025 Revenue: $1.49 billion, consistent with guidance; foreign currency headwind of approximately $13.4 million.

Adjusted EPS for 2025: $1.27, up 51% from $0.84 in 2024.

Gross Margin: Q4 at 70.7%, down from 71.4% YoY; core Nu Skin gross margin at 77.6%, up 100 basis points YoY.

Operating Margin: 6.3% for Q4; adjusted operating margin for the year at 6.7%, up 140 basis points YoY.

Cash Flow: $80.3 million from operations; $240 million in cash and $224 million in debt, indicating a strong balance sheet.

2Strategic Updates and Business Highlights

Transformation Focus: Emphasis on becoming a leading intelligent beauty, wellness, and lifestyle platform.

Prysm iO Launch: Introduction of an intelligent wellness platform aimed at enhancing customer engagement and lifetime value; targeting placement of over 100,000 devices by year-end 2026.

Expansion into India: Premarket operations initiated in November 2025, with a formal launch expected in late 2026; strategic focus on local manufacturing and digital infrastructure.

Emerging Market Growth: Continued success in Latin America and plans for expansion into India, leveraging insights from existing operations.

3Forward Guidance and Outlook

2026 Revenue Projection: Expected between $1.35 billion and $1.5 billion, with a foreign exchange headwind of $13 million to $15 million.

2026 EPS Guidance: Anticipated between $0.80 and $1.20, reflecting a higher expected tax rate of 35%.

Q1 2026 Revenue Guidance: Projected between $320 million and $340 million, historically the lowest quarter due to seasonality.

4Bad News, Challenges, or Points of Concern

Gross Margin Decline: Slight decrease in Q4 gross margin due to promotional activities; ongoing pressures from competitive pricing and market dynamics.

Operational Transition Costs: Transitioning to new business practices may incur switching costs into early 2026, impacting short-term performance.

Market Entry Risks: Entering India presents challenges, including high import duties and the need for robust local infrastructure; cautious revenue forecasts reflect these uncertainties.

5Notable Q&A Insights

Prysm iO Revenue Potential: While initial device sales are projected at $30 million, the subscription revenue model remains uncertain as the company is still learning about customer uptake.

India Market Strategy: Emphasis on establishing local manufacturing and logistics; cautious optimism about long-term potential despite acknowledging longer sales cycles.

Operational Leverage: Management is focused on aligning G&A expenses with revenue growth while maintaining a flexible cost structure to support strategic initiatives. Overall, Nu Skin's Q4 2025 results reflect a solid financial performance amid ongoing strategic transformations, with a focus on innovative product launches and market expansion, albeit tempered by operational challenges and market entry risks.

SOURCE: Q4 2025 EARNINGS CALL TRANSCRIPT